Pre-market
Loading markets…

Advertisement

Stocks

What's Going On With Kits Eyecare Ltd Stock Friday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:KITS.TO

Follow KITS

Photos provided by Pexels

Kits Eyecare Ltd stock has seen a notable uptick this week, following positive financial results and a growing customer base.

Kits Eyecare Ltd (KITS.TO) has experienced a positive week, with shares rising by 6.55% as of Friday's close. The company recently reported record financial results, which have likely contributed to investor optimism.

Advertisement

Kits Eyecare Ltd

KITS.TO

Full stock page →

KITS.TO

Kits Eyecare Ltd

Source:WealthAwesomeWealthAwesome
↑ $1.54 (10.26%)
120 day period
$10.84$14.17$17.50Apr 21Jul 16Oct 9

Market cap

$562.80M

P/E

97.4x

52W high

$22.56

52W low

$10.61

1W change

+0.73%

Beta

0.43

Analyst Price Targets

Based on analyst covering KITS · as of Sep 17, 2026

📈

Wall Street analysts forecast KITS stock price to rise 38.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$22.93

+38.5% Upside

Current Price

C$16.55

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on KITS's historical volatility

HistoricalForecast68%95%
C$11.67C$16.04C$20.41C$24.77C$29.14C$33.50TodayJun 3Aug 7Oct 9Nov 21Jan 4Feb 16

30-Day Vol

41.6%

Annualized

90-Day Vol

46.2%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$19.79

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$17.57C$15.22 – C$20.28
60 trading daysC$18.64C$15.22 – C$22.84
90 trading daysC$19.79C$15.43 – C$25.37

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Kits Eyecare's strong quarterly performance and expanding customer base suggest a bullish outlook. However, the stock's high P/E ratio and recent volatility may warrant caution for potential investors.

Kits Eyecare's Revenue Growth Reaches 23% Year-Over-Year

The company reported record first-quarter 2026 results with revenues of $57.5 million, driven by a 61% increase in glasses sales, highlighting a strong market position.

Bull case

Kits Eyecare has shown impressive revenue growth and now has over one million active customers, reflecting strong demand for its products. Analysts are optimistic, with an average target price indicating significant upside potential.

Bear case

Despite the recent growth, Kits Eyecare's high P/E ratio of 95.06 may suggest that the stock is overvalued. Additionally, the stock has dropped more than 20% year-to-date, raising concerns about its long-term performance.

Recent Price Action

Kits Eyecare Ltd's stock closed at C$15.26 on Friday, reflecting a 0.53% increase for the day and a notable 6.55% rise over the week. The stock has gained 13.01% over the past month, although it remains down 20.32% year-to-date.

Advertisement

Company News and Catalysts

Kits Eyecare has recently published impressive financial results, reporting a 23% year-over-year revenue increase for Q1 2026, amounting to $57.5 million. This growth was significantly driven by a 61% increase in glasses revenue, reaching $10.8 million. The company also announced that it has surpassed one million active customers, doubling its customer base since its IPO in 2021. These developments have likely contributed to the recent uptick in stock price.

Technical Picture

From a technical perspective, Kits Eyecare's stock is currently trading above its 50-day moving average of C$13.75, indicating a bullish trend. However, it is slightly below its 200-day moving average of C$15.39. The stock has a beta of 0.21, suggesting lower volatility compared to the broader market. The latest trading volume of 31,815 shares is notably lower than the 20-day average volume of 91,476 shares, indicating reduced trading activity.

Insider Activity

No recent insider activity has been reported for Kits Eyecare Ltd.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 21, 2026
Last Updated: September 26, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement